世卫组织网络进行的新候选疫苗病毒开发工作在不断提高产量(目前某些生产商的产量达季节性流感正常产量的25% - 50%)。
The development of new candidate vaccine viruses by the WHO network is continuing to improve yields (currently 25% to 50 % of the normal yields for seasonal influenza for some manufacturers).
五个非洲国家目前正在开展候选艾滋病毒疫苗的一期和二期临床试验:博茨瓦纳、肯尼亚、卢旺达、南非、乌干达,坦桑尼亚很快也将介入。
Five African countries are currently conducting phase I and phase II clinical trials of candidate HIV vaccines: Botswana, Kenya, Rwanda, South Africa, Uganda, soon to be joined by Tanzania.
Newman教授和博士候选人CarmenLogie从此前做过的30篇关于HIV病毒疫苗可接受性的论文中得出了这些结论的,这些论文调查了接近12000名群众。
Newman and PhD candidate Carmen Logie drew conclusions from 30 previous research papers involving nearly 12,000 people on the topic of HIV vaccine acceptability.
Newman教授和博士候选人CarmenLogie从此前做过的30篇关于HIV病毒疫苗可接受性的论文中得出了这些结论的,这些论文调查了接近12000名群众。
Newman and PhD candidate Carmen Logie drew conclusions from 30 previous research papers involving nearly 12, 000 people on the topic of HIV vaccine acceptability.
一旦某种已有候选疫苗的病毒对人类构成了威胁,再快速地组织规模更大费用更高人类药效测试。
If a disease for which there are candidate vaccines does become threatening, larger and more expensive human-efficacy trials can be organised quickly in response.
这种疫苗已经在动物研究中成功,新的实验将测试镶嵌疫苗的概念以及是否可能产生下一代的艾滋病毒候选疫苗。
Such vaccines have shown success in animal studies, and new trials will test the Mosaic concept and could possibly lead to the next generation of HIV vaccine candidates.
治疗性疫苗候选物靶向刺激CD4(+)和CD8(+)T细胞应答和诱导能够控制病毒复制的促炎细胞因子。
The therapeutic vaccine candidate targeted the stimulation of CD4(+) and CD8(+) T-cell responses and the induction of pro-inflammatory cytokines capable of controlling viral replication.
治疗性疫苗候选物靶向刺激CD4(+)和CD8(+)T细胞应答和诱导能够控制病毒复制的促炎细胞因子。
The therapeutic vaccine candidate targeted the stimulation of CD4(+) and CD8(+) T-cell responses and the induction of pro-inflammatory cytokines capable of controlling viral replication.
应用推荐